Celecoxib Inhibits Cellular Growth, Decreases Ki-67 Expression and Modifies Apoptosis in Ovarian Cancer Cell Lines
- 1 August 2006
- journal article
- Published by Elsevier in Archives of Medical Research
- Vol. 37 (6) , 689-695
- https://doi.org/10.1016/j.arcmed.2005.11.014
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cancer of the OvaryNew England Journal of Medicine, 2004
- Novel Insights and Therapeutical Applications in the Field of Inhibitors of COX-2Current Medicinal Chemistry, 2004
- Cyclooxygenases in cancer: progress and perspectiveCancer Letters, 2004
- Targeting cyclooxygenase-2 in human neoplasiaCancer Cell, 2003
- The use of dimethylsulfoxide as a vehicle in cell culture experiments using ovarian carcinoma cell linesBiotechnic & Histochemistry, 2003
- Paradigms for primary prevention of ovarian carcinoma.CA: A Cancer Journal for Clinicians, 2002
- Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical IssuesJNCI Journal of the National Cancer Institute, 2002
- Aspirin and Epithelial Ovarian CancerPreventive Medicine, 2001
- Expression of p160erbB-3 and p185erbB-2 in Prostatic Intraepithelial Neoplasia and Prostatic AdenocarcinomaJNCI Journal of the National Cancer Institute, 1994
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970